[{"address1": "331 Oyster Point Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 481 6770", "website": "https://pliantrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of av\u00df6 and av\u00df1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of av\u00df1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins av\u00df8 and av\u00df1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 171, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernard  Coulie M.B.A., M.D., Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 996968, "exercisedValue": 5432729, "unexercisedValue": 7282323}, {"maxAge": 1, "name": "Dr. Keith Lamont Cummings M.B.A., M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 684144, "exercisedValue": 1694253, "unexercisedValue": 2111570}, {"maxAge": 1, "name": "Mr. Mike  Ouimette J.D.", "age": 50, "title": "Chief Legal & Compliance Officer and Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 606028, "exercisedValue": 322078, "unexercisedValue": 198044}, {"maxAge": 1, "name": "Mr. Johannes P. Hull", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 602513, "exercisedValue": 189873, "unexercisedValue": 1831996}, {"maxAge": 1, "name": "Dr. Eric A. Lefebvre M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 734411, "exercisedValue": 0, "unexercisedValue": 2070744}, {"maxAge": 1, "name": "Dr. Rik  Derynck Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dean  Sheppard M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  DeGrado Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hal  Chapman M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Imbert Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.31, "open": 1.26, "dayLow": 1.24, "dayHigh": 1.35, "regularMarketPreviousClose": 1.31, "regularMarketOpen": 1.26, "regularMarketDayLow": 1.24, "regularMarketDayHigh": 1.35, "payoutRatio": 0.0, "beta": 1.47, "forwardPE": -0.33333334, "volume": 1411955, "regularMarketVolume": 1411955, "averageVolume": 2653658, "averageVolume10days": 1543260, "averageDailyVolume10Day": 1543260, "bid": 1.29, "ask": 1.37, "bidSize": 1, "askSize": 1, "marketCap": 82056648, "fiftyTwoWeekLow": 1.24, "fiftyTwoWeekHigh": 16.52, "fiftyDayAverage": 4.0034, "twoHundredDayAverage": 10.65445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -213475376, "profitMargins": 0.0, "floatShares": 50199674, "sharesOutstanding": 61236300, "sharesShort": 3978061, "sharesShortPriorMonth": 3535747, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.065, "heldPercentInsiders": 0.03272, "heldPercentInstitutions": 1.17049, "shortRatio": 1.07, "shortPercentOfFloat": 0.0664, "impliedSharesOutstanding": 61236300, "bookValue": 4.996, "priceToBook": 0.26821458, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -210304000, "trailingEps": -3.47, "forwardEps": -4.02, "enterpriseToEbitda": 0.944, "52WeekChange": -0.9089674, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 1.34, "targetHighPrice": 47.0, "targetLowPrice": 1.5, "targetMeanPrice": 10.0625, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 355724000, "totalCashPerShare": 5.809, "ebitda": -226240000, "totalDebt": 60192000, "quickRatio": 10.778, "currentRatio": 10.906, "debtToEquity": 19.795, "returnOnAssets": -0.314, "returnOnEquity": -0.54087, "freeCashflow": -98528128, "operatingCashflow": -155503008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.2900832, "regularMarketPrice": 1.34, "corporateActions": [], "marketState": "CLOSED", "postMarketTime": 1743806706, "regularMarketTime": 1743796801, "exchange": "NMS", "messageBoardId": "finmb_325980525", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Pliant Therapeutics, Inc.", "longName": "Pliant Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591191000000, "postMarketChangePercent": 3.64925, "postMarketPrice": 1.3889, "postMarketChange": 0.0489, "regularMarketChange": 0.03000009, "regularMarketDayRange": "1.24 - 1.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2653658, "fiftyTwoWeekLowChange": 0.100000024, "fiftyTwoWeekLowChangePercent": 0.08064518, "fiftyTwoWeekRange": "1.24 - 16.52", "fiftyTwoWeekHighChange": -15.18, "fiftyTwoWeekHighChangePercent": -0.9188862, "fiftyTwoWeekChangePercent": -90.896736, "earningsTimestamp": 1741035600, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.47, "epsForward": -4.02, "epsCurrentYear": -2.29183, "priceEpsCurrentYear": -0.5846856, "fiftyDayAverageChange": -2.6633997, "fiftyDayAverageChangePercent": -0.66528445, "twoHundredDayAverageChange": -9.31445, "twoHundredDayAverageChangePercent": -0.8742309, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-03", "cryptoTradeable": false, "displayName": "Pliant Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]